BIO
Bio-Rad Laboratories, Inc.Class A
stockNYSE
At CloseNov 6, 2026 3:59:53 PM EST
381.90USD+3.496%(+12.90)273,161
BIO Financials
In Q3 FY 2026 (ended ), Bio-Rad Laboratories, Inc.Class A (BIO) reported revenue of $656.4M, net income of $458.6M, operating cash flow of $96.4M, and assets of $10.78B (filed ).
Loading financial statements…